project id: TCGA-LUSC; case submitter id: TCGA-56-A62T; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; normal tumor genotype snp match: Yes; age at index: 78; days to birth: -28522; ethnicity: not hispanic or latino; gender: male; race: black or african american; vital status: Alive; year of birth: 1935; age at diagnosis: 28522; ajcc pathologic m: MX; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIA; ajcc pathologic t: T2b; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 440.0; icd 10 code: C34.1; last known disease status: not reported; morphology: 8070/3; primary diagnosis: Squamous cell carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Upper lobe, lung; synchronous malignancy: No; tissue or organ of origin: Upper lobe, lung; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: yes; alcohol history: Not Reported; cigarettes per day: 5.589041095890411; pack years smoked: 102.0; is ffpe: false; composition: Not Reported; days to collection: 41; days to sample procurement: 0; initial weight: 40.0; portion submitter id: TCGA-56-A62T-01A-11; percent lymphocyte infiltration: 5.0; percent monocyte infiltration: 1.0; percent necrosis: 2.0; percent neutrophil infiltration: 1.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 98.0; percent tumor nuclei: 75.0;